Tirupati Starch & Chemicals Ltd Q3 FY26: ₹91.94 Cr Sales, EPS ₹2.57, Margins Slip & Rating Outlook Turns Negative — Is This Maize Machine Losing Steam?

1. At a Glance – The Corn Chronicles Begin 🌽

₹156 crore market cap. ₹163 stock price. P/E at 27.6. ROE at 13.2%. Debt at ₹136 crore. Interest coverage barely breathing at 1.78x. And the latest quarter? Sales at ₹91.94 crore, PAT at ₹2.46 crore, and profit down a brutal 66.9% YoY.

Welcome to Tirupati Starch & Chemicals Ltd, the company that converts humble maize into starch, dextrose and derivatives — and sometimes converts investor confidence into confusion.

In Q3 FY26 (Dec 2025 quarter), revenue dipped 7.34% YoY. Profit took a deeper cut. Margins are thin like papad. Meanwhile, Acuité reaffirmed the rating at BBB but changed the outlook from Stable to Negative in Feb 2026.

So what’s cooking here? Is this a temporary margin squeeze? Or is the maize cycle chewing them up?

Grab your popcorn. Or better — cornflakes.

2. Introduction – From Cornfield to Balance Sheet

Established in 1985 in Indore, Tirupati Starch is a classic agro-processing story.

Maize comes in.
Starch and dextrose go out.
Margins swing.
Investors sweat.

The company operates in the maize-processing segment — a sector where pricing power is like Wi-Fi in a village wedding: technically available, practically unstable.

Over FY25, the company did manage to improve performance:

• Revenue: ₹390.05 crore (vs ₹306.34 crore in FY24)
• PAT: ₹7.54 crore (vs ₹2.07 crore)
• Operating margin: 7.32%

Sounds decent, right?

But 9M FY26 numbers tell a different story:

• Revenue: ₹273.40 crore (down from ₹288.72 crore)
• EBITDA: ₹17.07 crore (vs ₹21.02 crore)
• PAT: ₹4.13 crore (vs ₹6.00 crore)

Margins are under pressure. Coverage metrics are tight. Working capital utilisation remains high.

And remember — maize prices are volatile. This isn’t software. This is agriculture. One bad monsoon and the spreadsheet cries.

Question for you: When a commodity processor trades at 27x earnings, are you paying for stability or hope?

3. Business Model – WTF Do They Even Do?

Let’s simplify.

They buy maize.
They crush maize.
They extract starch and derivatives.
They sell to food, pharma, and industrial players.

Main products:

• Maize Starch
• Dextrose Anhydrous
• Dextrose Monohydrate
• Dextrin
• Liquid Glucose

By-products:

• Maize Bran
• Maize Gluten
• Cattle Feed
• Germ
• Husk

Revenue mix (FY22):

• Starch: 90%
• Dextrose: 7%
• Monohydrate: 1%
• Others: 2%

So essentially, this is a starch-heavy business.

Exports? Barely 1.2% of FY22 revenue. Mostly domestic.

And what drives profits?

1. Maize prices.
2. Energy cost.
3. Volume.
4. Ability to pass cost increases.

The industry is fragmented. Pricing power is limited. And raw material volatility